Evidence map

ArticleReviews in endocrine & metabolic disorders2026

Use of osilodrostat in a block-and-replace and titration strategy for cushing's syndrome: a position paper by French experts.

Frédéric Castinetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41760839